fidarestat has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pal, PB; Ramana, KV; Shukla, K; Sonowal, H; Srivastava, SK | 2 |
2 other study(ies) available for fidarestat and Hyperglycemia
| Article | Year |
|---|---|
Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant Proteins.
Topics: Aldehyde Reductase; Animals; Catalase; Cell Survival; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; Heme Oxygenase-1; Hyperglycemia; Imidazolidines; Kidney; Membrane Proteins; Mice; Monocytes; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Superoxide Dismutase | 2017 |
Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway.
Topics: Aldehyde Reductase; AMP-Activated Protein Kinases; Animals; bcl-2-Associated X Protein; Caspase 3; Cell Death; Cell Survival; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Imidazolidines; Intercellular Adhesion Molecule-1; Male; Mice; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sirtuin 1; THP-1 Cells; TOR Serine-Threonine Kinases; Vascular Cell Adhesion Molecule-1 | 2019 |